43 filings
6-K
MITO
Stealth BioTherapeutics Corp
16 Nov 22
Stealth BioTherapeutics Corp Announces Completion of Merger
4:08pm
6-K
MITO
Stealth BioTherapeutics Corp
7 Oct 22
Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders
4:10pm
6-K
MITO
Stealth BioTherapeutics Corp
30 Sep 22
Current report (foreign)
5:10pm
6-K
MITO
Stealth BioTherapeutics Corp
19 Aug 22
Current report (foreign)
4:15pm
6-K
MITO
Stealth BioTherapeutics Corp
1 Aug 22
Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction
8:38am
6-K
ybbhz
11 Jul 22
Stealth Biotherapeutics Announces Receipt of Non-compliance Notice from Nasdaq
5:20pm
6-K
lurejnfockh
27 Jun 22
Stealth BioTherapeutics Corp Announces Receipt of Preliminary
8:02am
6-K
440e8h89p
18 May 22
Current report (foreign)
8:16am
6-K
uqk7mi8ju eskw1i
11 Apr 22
Current report (foreign)
8:41am
6-K
z2p7o4by
18 Mar 22
Current report (foreign)
4:46pm
6-K
4ao5e1k9ylndrg3
14 Feb 22
Stealth Biotherapeutics Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Requirement
12:00am
6-K
ioy5blyynzicpjy94gq
7 Jan 22
Stealth Biotherapeutics Receives Nasdaq Notifications Regarding Minimum Bid and Market Value Requirements
4:40pm
6-K
vdbp7p t5ofh
12 Nov 21
Stealth Biotherapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights
8:15am
6-K
66kpfxhvslkxwg5
20 Oct 21
Current report (foreign)
7:50am
6-K
bykhnaoqfq0339zo5
4 Oct 21
Current report (foreign)
7:45am
6-K
1gfcine
5 Aug 21
Current report (foreign)
4:47pm
6-K
34bdfob nos6
5 Aug 21
Stealth Biotherapeutics Reports Second Quarter 2021 Financial Results and Recent Business Highlights
8:10am
6-K
2xws3
20 Jul 21
6-K Annual Meeting Results
4:11pm
6-K
h3jdfr2
15 Jun 21
6-K for Annual Proxy
4:30pm
6-K
fudl8e5ks7oehat9
18 May 21
Stealth Biotherapeutics Announces Additional Development Financing to Advance Elamipretide Clinical Trials
8:21am